Salah Abdelrazig1, Catharine A Ortori1, Michael Doherty2,3,4,5, Ana M Valdes2,3, Victoria Chapman2,4,6, David A Barrett7. 1. Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK. 2. Pain Centre Versus Arthritis, Queen's, Medical Centre, Medical School, University of Nottingham, Nottingham, NG7 2RD, UK. 3. School of Medicine, University of Nottingham, Nottingham, NG7 2RD, UK. 4. NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, NG7 2RD, UK. 5. Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis, University of Nottingham, Nottingham, NG7 2RD, UK. 6. School of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, UK. 7. Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK. David.barrett@nottingham.ac.uk.
Abstract
INTRODUCTION: Osteoarthritis (OA) is a common cause of disability in older people, but its aetiology is not yet fully understood. Biomarkers of OA from metabolomics studies have shown potential use in understanding the progression and pathophysiology of OA. OBJECTIVES: To investigate possible surrogate biomarkers of knee OA in urine using metabolomics to contribute towards a better understanding of OA progression and possible targeted treatment. METHOD: Liquid chromatography-high resolution mass spectrometry (LC-HRMS) was applied in a case-control approach to explore the possible metabolic differences between the urinary profiles of symptomatic knee OA patients (n = 74) (subclassified into inflammatory OA, n = 22 and non-inflammatory OA, n = 52) and non-OA controls (n = 68). Univariate, multivariate and pathway analyses were performed with a rigorous validation including cross-validation, permutation test, prediction and receiver operating characteristic curve to identify significantly altered metabolites and pathways in OA. RESULTS: OA datasets generated 7405 variables and multivariate analysis showed clear separation of inflammatory OA, but not non-inflammatory OA, from non-OA controls. Adequate cross-validation (R2Y = 0.874, Q2 = 0.465) was obtained. The prediction model and the ROC curve showed satisfactory results with a sensitivity of 88%, specificity of 71% and accuracy of 77%. 26 metabolites were identified as potential biomarkers of inflammatory OA using HMDB, authentic standards and/or MS/MS database. CONCLUSION: Urinary metabolic profiles were altered in inflammatory knee OA subjects compared to those with non-inflammatory OA and non-OA controls. These altered profiles associated with perturbed activity of the TCA cycle, pyruvate and amino acid metabolism linked to inflammation, oxidative stress and collagen destruction. Of note, 2-keto-glutaramic acid level was > eightfold higher in the inflammatory OA patients compared to non-OA control, signalling a possible perturbation in glutamine metabolism related to OA progression.
INTRODUCTION:Osteoarthritis (OA) is a common cause of disability in older people, but its aetiology is not yet fully understood. Biomarkers of OA from metabolomics studies have shown potential use in understanding the progression and pathophysiology of OA. OBJECTIVES: To investigate possible surrogate biomarkers of knee OA in urine using metabolomics to contribute towards a better understanding of OA progression and possible targeted treatment. METHOD: Liquid chromatography-high resolution mass spectrometry (LC-HRMS) was applied in a case-control approach to explore the possible metabolic differences between the urinary profiles of symptomatic knee OA patients (n = 74) (subclassified into inflammatory OA, n = 22 and non-inflammatory OA, n = 52) and non-OA controls (n = 68). Univariate, multivariate and pathway analyses were performed with a rigorous validation including cross-validation, permutation test, prediction and receiver operating characteristic curve to identify significantly altered metabolites and pathways in OA. RESULTS: OA datasets generated 7405 variables and multivariate analysis showed clear separation of inflammatory OA, but not non-inflammatory OA, from non-OA controls. Adequate cross-validation (R2Y = 0.874, Q2 = 0.465) was obtained. The prediction model and the ROC curve showed satisfactory results with a sensitivity of 88%, specificity of 71% and accuracy of 77%. 26 metabolites were identified as potential biomarkers of inflammatory OA using HMDB, authentic standards and/or MS/MS database. CONCLUSION: Urinary metabolic profiles were altered in inflammatory knee OA subjects compared to those with non-inflammatory OA and non-OA controls. These altered profiles associated with perturbed activity of the TCA cycle, pyruvate and amino acid metabolism linked to inflammation, oxidative stress and collagen destruction. Of note, 2-keto-glutaramic acid level was > eightfold higher in the inflammatory OA patients compared to non-OA control, signalling a possible perturbation in glutamine metabolism related to OA progression.
Authors: A K Carlson; R A Rawle; C W Wallace; E G Brooks; E Adams; M C Greenwood; M Olmer; M K Lotz; B Bothner; R K June Journal: Osteoarthritis Cartilage Date: 2019-04-25 Impact factor: 6.576
Authors: L Menashe; K Hirko; E Losina; M Kloppenburg; W Zhang; L Li; D J Hunter Journal: Osteoarthritis Cartilage Date: 2011-10-19 Impact factor: 6.576
Authors: Gemma M Kirwan; Erik Johansson; Robert Kleemann; Elwin R Verheij; Åsa M Wheelock; Susumu Goto; Johan Trygg; Craig E Wheelock Journal: Anal Chem Date: 2012-08-02 Impact factor: 6.986
Authors: Lloyd W Sumner; Alexander Amberg; Dave Barrett; Michael H Beale; Richard Beger; Clare A Daykin; Teresa W-M Fan; Oliver Fiehn; Royston Goodacre; Julian L Griffin; Thomas Hankemeier; Nigel Hardy; James Harnly; Richard Higashi; Joachim Kopka; Andrew N Lane; John C Lindon; Philip Marriott; Andrew W Nicholls; Michael D Reily; John J Thaden; Mark R Viant Journal: Metabolomics Date: 2007-09 Impact factor: 4.290
Authors: David J Hunter; Philippa J A Nicolson; Christopher B Little; Sarah R Robbins; Xia Wang; Kim L Bennell Journal: BMC Musculoskelet Disord Date: 2019-02-13 Impact factor: 2.362
Authors: Chwan-Li Shen; Bruce A Watkins; Chanaka Kahathuduwa; Ming-Chien Chyu; Masoud Zabet-Moghaddam; Moamen M Elmassry; Hui-Ying Luk; Jean-Michel Brismée; Ami Knox; Jaehoon Lee; Mimi Zumwalt; Rui Wang; Tor D Wager; Volker Neugebauer Journal: Front Med (Lausanne) Date: 2022-01-03